Are you Dr. Nair?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2115 S Fremont Ave
Suite 1000
Springfield, MO 65804Phone+1 417-820-8099Fax+1 417-820-8093
Summary
- Dr. Rajesh Nair, MD is an oncologist in Springfield, Missouri. He is currently licensed to practice medicine in Missouri. He is affiliated with Mercy Hospital Springfield.
Education & Training
SSM Health/Saint Louis University School of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2008- SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2002 - 2005
University of Kerala Medical CollegeClass of 2000
Certifications & Licensure
MO State Medical License 2008 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment Start of enrollment: 2012 Jul 01
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
- Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE) Start of enrollment: 2015 May 01
Publications & Presentations
PubMed
- 114 citationsStat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance.Nadine N. Bewry, Rajesh R. Nair, Michael F. Emmons, David Boulware, Javier Pinilla-Ibarz
Molecular Cancer Therapeutics. 2008-10-01 - 8 citationsCombination of cabazitaxel and plicamycin induces cell death in drug resistant B-cell acute lymphoblastic leukemiaRajesh R. Nair, Debbie Piktel, Werner J. Geldenhuys, Laura F. Gibson
Leukemia Research. 2018-08-06 - 20 citationsMTI-101 (Cyclized HYD1) Binds a CD44 Containing Complex and Induces Necrotic Cell Death in Multiple MyelomaAnthony W. Gebhard, Priyesh Jain, Rajesh R. Nair, Michael F. Emmons, Raul F. Argilagos
Molecular Cancer Therapeutics. 2013-11-01
Authored Content
- Combination of Cabazitaxel and Plicamycin Induces Cell Death in Drug Resistant B-cell Acute Lymphoblastic LeukemiaAugust 2018
Press Mentions
Some TikTok Influencers Are Maligning Sunscreen. Here's What to Know About the ClaimsJune 27th, 2024
Other Languages
- German, Malay
